Ho Tsoi
7PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Sep 13, 2025
BQ323636.1 Employs the AR-CCRK Axis to Modulate the Expression of KU70 to Interfere with Non-Homologous End Joining Mediated DNA Repair Mechanism.Ho Tsoi, Zi-Qing So, Ellen P S Man
|Jun 13, 2025
The Splice Variant of the NCOR2 Gene BQ323636.1 Modulates ACSL4 Expression to Enhance Fatty Acid Metabolism and Support of Tumor Growth in Breast Cancer.Ho Tsoi, Chan-Ping You, Koei Ho-Lam Cheung
|Aug 29, 2024
Correction: Tsoi et al. Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. <i>Life</i> 2022, <i>12</i>, 93.Ho Tsoi, Ling Shi, Man-Hong Leung
|May 16, 2023
SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer.Ho Tsoi, Nicholas Nok-Ching Fung, Ellen P S Man
|Dec 11, 2022
Modulating the Activity of Androgen Receptor for Treating Breast Cancer.Chan-Ping You, Ho Tsoi, Ellen P S Man
|Oct 27, 2022
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer.Ho Tsoi, Wai-Chung Tsang, Ellen P S Man
Pageof 2
